| Q36807586 | Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients |
| Q33753751 | Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. |
| Q35579255 | Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study |
| Q42369766 | Coagulofibrinolytic Changes in Patients with Post-cardiac Arrest Syndrome |
| Q28488062 | Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers |
| Q33615237 | Diverse coagulopathies in a rabbit model with different abdominal injuries |
| Q34789731 | Effect of mild hypothermia on the coagulation-fibrinolysis system and physiological anticoagulants after cardiopulmonary resuscitation in a porcine model |
| Q37144751 | Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac arrest s |
| Q35822899 | Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock |
| Q35207771 | Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy |
| Q58740078 | Increased Fibrinolysis as a Specific Marker of Poor Outcome After Cardiac Arrest |
| Q36396010 | Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients |
| Q45375279 | Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient |
| Q90614358 | Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays |
| Q38115586 | Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate |
| Q37633753 | Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism |
| Q36390547 | Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation |
| Q36335991 | Thromboelastometric analysis of the risk factors for return of spontaneous circulation in adult patients with out-of-hospital cardiac arrest |
| Q49200827 | Tissue injury suppresses fibrinolysis after hemorrhagic shock in nonhuman primates (rhesus macaque). |
| Q33676496 | Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis |
| Q40577604 | Uncritical use of tranexamic acid in trauma patients : Do no further harm! |
| Q38776292 | Viscoelastic Tissue Plasminogen Activator Challenge Predicts Massive Transfusion in 15 Minutes |
| Q36818081 | Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients |